206 related articles for article (PubMed ID: 36965839)
1. Excess body weight: Novel insights into its roles in obesity comorbidities.
Zhang X; Ha S; Lau HC; Yu J
Semin Cancer Biol; 2023 Jul; 92():16-27. PubMed ID: 36965839
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
3. Overview of epidemiology and contribution of obesity to cardiovascular disease.
Bastien M; Poirier P; Lemieux I; Després JP
Prog Cardiovasc Dis; 2014; 56(4):369-81. PubMed ID: 24438728
[TBL] [Abstract][Full Text] [Related]
4. Metabolically healthy obese individuals -- mechanisms and clinical relevance.
Hrasko T; Bendlová B; Hainer V; Haluzík M
Cesk Fysiol; 2016 Oct; 65(1):38-46. PubMed ID: 29489091
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous Comorbidity in Individuals With Different Phenotypes of Obesity.
Nurieva AR; Parve SD; Sineglazova AV
Cureus; 2023 May; 15(5):e38995. PubMed ID: 37323325
[TBL] [Abstract][Full Text] [Related]
6. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes.
Yang YK; Chen M; Clements RH; Abrams GA; Aprahamian CJ; Harmon CM
Cell Physiol Biochem; 2008; 22(5-6):531-8. PubMed ID: 19088435
[TBL] [Abstract][Full Text] [Related]
7. Adult weight change in relation to visceral fat and liver fat at middle age: The Netherlands epidemiology of obesity study.
Verkouter I; Noordam R; de Roos A; Lamb HJ; Rosendaal FR; van Heemst D; de Mutsert R
Int J Obes (Lond); 2019 Apr; 43(4):790-799. PubMed ID: 30026588
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of abdominal adipose tissue depots in health and disease.
Walker GE; Marzullo P; Ricotti R; Bona G; Prodam F
Horm Mol Biol Clin Investig; 2014 Jul; 19(1):57-74. PubMed ID: 25390016
[TBL] [Abstract][Full Text] [Related]
9. Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity.
Portela ND; Galván C; Sanmarco LM; Bergero G; Aoki MP; Cano RC; Pesoa SA
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986134
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
13. What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
Cuthbertson DJ; Steele T; Wilding JP; Halford JC; Harrold JA; Hamer M; Karpe F
Int J Obes (Lond); 2017 Jun; 41(6):853-865. PubMed ID: 28077863
[TBL] [Abstract][Full Text] [Related]
14. Childhood obesity, adipose tissue distribution, and the pediatric practitioner.
Slyper AH
Pediatrics; 1998 Jul; 102(1):e4. PubMed ID: 9651456
[TBL] [Abstract][Full Text] [Related]
15. Physiological and Lifestyle Traits of Metabolic Dysfunction in the Absence of Obesity.
Klitgaard HB; Kilbak JH; Nozawa EA; Seidel AV; Magkos F
Curr Diab Rep; 2020 Mar; 20(6):17. PubMed ID: 32232577
[TBL] [Abstract][Full Text] [Related]
16. Role of diet and nutritional management in non-alcoholic fatty liver disease.
Fan JG; Cao HX
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
[TBL] [Abstract][Full Text] [Related]
17. Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity.
Landgraf K; Schuster S; Meusel A; Garten A; Riemer T; Schleinitz D; Kiess W; Körner A
BMC Physiol; 2017 Mar; 17(1):4. PubMed ID: 28327129
[TBL] [Abstract][Full Text] [Related]
18. Adipose Tissue Inflammation and Cardiovascular Disease: An Update.
Rana MN; Neeland IJ
Curr Diab Rep; 2022 Jan; 22(1):27-37. PubMed ID: 35179694
[TBL] [Abstract][Full Text] [Related]
19. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes.
González N; Moreno-Villegas Z; González-Bris A; Egido J; Lorenzo Ó
Cardiovasc Diabetol; 2017 Apr; 16(1):44. PubMed ID: 28376896
[TBL] [Abstract][Full Text] [Related]
20. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors.
Sitticharoon C; Chatree S; Churintaraphan M
Regul Pept; 2013 Aug; 185():65-72. PubMed ID: 23838112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
